tiprankstipranks
Apyx Medical Corporation (APYX)
NASDAQ:APYX
Holding APYX?
Track your performance easily

Apyx Medical (APYX) Earnings Date & Reports

191 Followers

Earnings Data

Report Date
Mar 13, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-$0.16
Last Year’s EPS
-$0.28
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 08, 2024
|
% Change Since: 28.69%
|
Next Earnings Date:Mar 13, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strategic initiatives such as the development of the Ayon platform and restructuring efforts to streamline operations and extend financial runway. Despite these positive steps and growth in disposable and OEM segments, the company faced challenges with declining revenue and sales in their Advanced Energy segment, attributed to macroeconomic factors. The sentiment is mixed as the company is taking proactive measures but currently faces significant market challenges.
Company Guidance
During the Apyx Medical Q3 2024 earnings call, the company provided guidance metrics reflecting strategic restructuring and financial projections. Apyx announced an organizational restructuring, reducing its U.S. workforce by nearly 25%, which is expected to save approximately $4.3 million annually and extend its financial runway into 2027. For 2024, Apyx revised its total revenue guidance to a range of $46.6 million to $47.6 million, a 9% to 11% decrease from the prior year, with Advanced Energy revenue projected between $37.2 million and $38.2 million. OEM revenue is anticipated to be around $9.4 million. Looking forward to 2025, the company introduced revenue guidance of $47.6 million to $49.5 million, reflecting 2% to 6% growth, driven by expected Advanced Energy revenue of $39.1 million to $41 million and a decrease in OEM revenue to $8.5 million. The company aims to manage operating expenses below $40 million, focusing on the introduction of its Ayon body contouring system and continued growth in disposable handpiece sales.
Introduction of Ayon Platform
Apyx Medical is developing the Ayon body contouring system, which integrates multiple functions into a single device. A 510(k) submission is planned for Q1 2025, with an expected launch in the second half of 2025.
Increase in Disposable Handpiece Revenue
Despite challenges, disposable handpiece revenue grew 9% overall and 15% in the U.S. Disposable revenue now accounts for more than 60% of total Advanced Energy revenue.
OEM Segment Growth
OEM segment sales increased by 3% in Q3 2024 compared to the same period in 2023.
Strategic Restructuring
Apyx Medical has restructured its organization, reducing its U.S. workforce by nearly 25% to extend operational runway into 2027.
Direct Investment and Covenant Amendments
Closed a $7 million investment from Nantahala Capital Management and amended revenue covenants with Perceptive Advisors.
---

Apyx Medical (APYX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

APYX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 13, 20252024 (Q4)
-0.16 / -
-0.28
Nov 08, 20242024 (Q3)
-0.18 / -0.14
-0.13-7.69% (-0.01)
Aug 08, 20242024 (Q2)
-0.20 / -0.19
-0.03-533.33% (-0.16)
May 09, 20242024 (Q1)
-0.22 / -0.22
-0.1-120.00% (-0.12)
Mar 21, 20242023 (Q4)
-0.18 / -0.28
-0.17-64.71% (-0.11)
Nov 09, 20232023 (Q3)
-0.11 / -0.13
-0.1723.53% (+0.04)
Aug 10, 20232023 (Q2)
-0.07 / -0.03
-0.1681.25% (+0.13)
May 11, 20232023 (Q1)
-0.14 / -0.10
-0.1741.18% (+0.07)
Mar 16, 20232022 (Q4)
-0.14 / -0.17
-0.06-183.33% (-0.11)
Nov 10, 20222022 (Q3)
-0.14 / -0.17
-0.12-41.67% (-0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

APYX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 08, 2024$1.22$1.52+24.59%
Aug 08, 2024$1.02$1.04+1.96%
May 09, 2024$1.35$1.66+22.96%
Mar 21, 2024$1.85$1.32-28.65%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Apyx Medical Corporation (APYX) report earnings?
Apyx Medical Corporation (APYX) is schdueled to report earning on Mar 13, 2025, TBA Not Confirmed.
    What is Apyx Medical Corporation (APYX) earnings time?
    Apyx Medical Corporation (APYX) earnings time is at Mar 13, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is APYX EPS forecast?
          APYX EPS forecast for the fiscal quarter 2024 (Q4) is -$0.16.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis